Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Non-Current Assets (2020 - 2025)

GeneDx Holdings has reported Non-Current Assets over the past 6 years, most recently at $255.4 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $255.4 million for Q4 2025, up 15.36% from a year ago — trailing twelve months through Dec 2025 was $991.4 million (up 9.88% YoY), and the annual figure for FY2025 was $255.4 million, up 15.36%.
  • Non-Current Assets for Q4 2025 was $255.4 million at GeneDx Holdings, roughly flat from $256.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for WGSWW hit a ceiling of $530.6 million in Q2 2022 and a floor of $64.8 million in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $233.8 million (2023), compared with a mean of $232.1 million.
  • Biggest five-year swings in Non-Current Assets: tumbled 85.35% in 2021 and later soared 705.55% in 2022.
  • GeneDx Holdings' Non-Current Assets stood at $70.5 million in 2021, then skyrocketed by 294.51% to $278.3 million in 2022, then decreased by 15.06% to $236.4 million in 2023, then dropped by 6.35% to $221.4 million in 2024, then rose by 15.36% to $255.4 million in 2025.
  • The last three reported values for Non-Current Assets were $255.4 million (Q4 2025), $256.3 million (Q3 2025), and $259.0 million (Q2 2025) per Business Quant data.